Evommune Starts Phase 2b Trial of EVO756 in Atopic...
Category : Approval/Launch 28 August 2025Evommune, Inc. has dosed the first patient in its Phase 2b trial of EVO756, an oral small molecule d...
Approval Launch
Navamedic Secures Final Approvals for Parkinson’s...
Category : Approval/Launch 18 August 2025Navamedic, a Nordic pharma player, just hit a key milestone. The company has received final approval...
Tonix Wins FDA Approval for Tonmya™, the First New...
Category : Approval/Launch 18 August 2025Tonix Pharmaceuticals has secured FDA approval for Tonmya™ (cyclobenzaprine HCl sublingual tab...
Zydus Lifesciences Secures USFDA Approval for Dilt...
Category : Approval/Launch 12 August 2025Ahmedabad – Zydus Lifesciences Limited has received final approval from the United States Food...
GC Biopharma Study Confirms Stability of ALYGLO® I...
Category : Approval/Launch 12 August 2025GC Biopharma USA has reported new data showing that pooled ALYGLO® (immune globulin intravenous,...
Latest Newsletter Post
-
Correctseq’s CS-101 Marks First Bas..
29 August 2025
-
Bristol Myers Squibb to Present New..
29 August 2025
-
Evommune Starts Phase 2b Trial of E..
28 August 2025
-
Ascletis’ ASC30 Shows Strong PK Dat..
28 August 2025
-
Eli Lilly’s Oral GLP-1 Pill Shows S..
27 August 2025
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com